Entry
Name
Complement and coagulation cascades - Homo sapiens (human)
Description
The complement system is a proteolytic cascade in blood plasma and a mediator of innate immunity, a nonspecific defense mechanism against pathogens. There are three pathways of complement activation: the classical pathway, the lectin pathway, and the alternative pathway. All of these pathways generate a crucial enzymatic activity that, in turn, generates the effector molecules of complement. The main consequences of complement activation are the opsonization of pathogens, the recruitment of inflammatory and immunocompetent cells, and the direct killing of pathogens. Blood coagulation is another series of proenzyme-to-serine protease conversions, culminating the formation of thrombin, the enzyme responsible for the conversion of soluble fibrinogen to the insoluble fibrin clot. Protease-activated receptors, such as those activated by thrombin, are members of G protein-coupled receptors and function as a mediator of innate immunity. The kallikrein-kinin system is an endogenous metabolic cascade, triggering of which results in the release of vasoactive kinins (bradykinin-related peptides). Kinin peptides are implicated in many physiological and pathological processes including the regulation of blood pressure and sodium homeostasis, inflammatory processes, and the cardioprotective effects of preconditioning.
Class
Organismal Systems; Immune system
BRITE hierarchy
Pathway map
hsa04610 Complement and coagulation cascades
Ortholog table
Network
Element
N01487 Classical pathway of complement cascade, C4/C2 to C3 convertase formation
N01489 Classical/Lectin pathway of complement cascade, C5 convertase formation
N01490 Common pathway of complement cascade, MAC formation
N01491 Lectin pathway of complement cascade, C4/C2 to C3 convertase formation
N01493 Alternative pathway of complement cascade, C3 convertase formation
N01494 Alternative pathway of complement cascade, C3/5 convertase formation
N01495 Classical/Lectin pathway of complement cascade, C4b breakdown
N01496 Alternative pathway of complement cascade, C3b breakdown
N01503 Extrinsic pathway of coagulation cascade, F7 activation
N01504 Regulation of complement cascade, CFHR
N01505 Regulation of complement cascade, MAC inhibition
N01506 Intrinsic pathway of coagulation cascade, F12 activation
N01507 Intrinsic pathway of coagulation cascade, F11 activation
N01508 Intrinsic pathway of coagulation cascade, F9 activation
N01509 Intrinsic pathway of coagulation cascade, F8 activation
N01510 Common pathway of coagulation cascade, F10 activation
N01511 Common pathway of coagulation cascade, F5 activation
N01512 Common pathway of coagulation cascade, prothrombin activation
N01513 Common pathway of coagulation cascade, fibrinogen to fibrin
N01514 Common pathway of coagulation cascade, F13 activation
N01515 Regulation of coagulation cascade, protein C system
N01516 Kallikrein-kinin system, prekallikrein activation
N01517 Kallikrein-kinin system, HMWK to bradykinin
N01519 Regulation of coagulation cascade, AT3
N01520 Regulation of fibrinolytic system, C1INH
N01521 Regulation of coagulation cascade, HCF2
N01522 Regulation of fibrinolytic system, AAP
N01523 Regulation of fibrinolytic system, AAT
N01524 Regulation of fibrinolytic system, PAI
Drug
D00160 Aminocaproic acid (USP/INN)
D01136 Tranexamic acid (JP18/USP/INN)
D01672 Gabexate mesilate (JP18)
D01844 Fondaparinux sodium (JAN/USP/INN)
D01981 Ximelagatran (JAN/USAN/INN)
D02112 Heparin sodium (JP18/USP/INN)
D02235 Desmopressin acetate (USP)
D02956 Anticoagulant heparin (USP)
D02980 Adomiparin sodium (USAN)
D03213 Apixaban (JAN/USAN/INN)
D03330 Kallidinogenase (JP18/INN)
D03353 Dalteparin sodium (JAN/USP/INN)
D03644 Danaparoid sodium (JAN/USAN)
D03673 Deligoparin sodium (USAN/INN)
D03674 Enoxaparin sodium (JAN/USP/INN)
D03722 Efegatran sulfate (USAN)
D04029 Razaxaban hydrochloride (USAN)
D04492 Icatibant acetate (JAN/USAN)
D04977 Parnaparin sodium (JP18)
D06398 Tinzaparin sodium (USAN)
D06410 Thrombomodulin alfa (USAN/INN)
D07082 Dabigatran etexilate mesylate (USAN)
D07086 Rivaroxaban (JAN/USAN/INN)
D07144 Dabigatran etexilate (USAN/INN)
D07568 Aminomethylbenzoic acid
D09546 Edoxaban tosilate hydrate (JAN)
D09766 Vorapaxar sulfate (JAN/USAN)
D09817 Darexaban maleate (JAN)
D09867 Atopaxar hydrobromide (USAN)
D10150 Pegnivacogin sodium (USAN)
D10418 Delparantag pentahydrochloride (USAN)
D10471 Idraparinux sodium (USAN)
D10484 Pegnivacogin (USAN/INN)
D10758 Turoctocog alfa pegol (genetical recombination) (JAN)
D11029 Andexanet alfa (USAN/INN)
D11093 Avacopan (JAN/USAN/INN)
D11160 Caplacizumab (USAN/INN)
D11280 Bivalirudin trifluoroacetate (USAN)
D11568 Edoxaban tosylate (USAN)
D11613 Pegcetacoplan (JAN/USAN/INN)
D11641 Danicopan (JAN/USAN/INN)
D11673 Berotralstat (USAN/INN)
D11674 Berotralstat hydrochloride (JAN/USAN)
D11748 Avacincaptad pegol sodium (USAN)
D11814 Tisotumab vedotin (USAN/INN)
D12252 Iptacopan hydrochloride (USAN)
D12356 Zilucoplan sodium (JAN)
D12396 Sebetralstat (JAN/USAN/INN)
D12421 Freeze-dried activated human blood coagulation factor VII concentrate containing factor X
D12434 Valoctocogene roxaparvovec (USAN/INN)
D12500 Etranacogene dezaparvovec (USAN/INN)
D12564 Frunexian hydrochloride (USAN)
D12574 Feniralstat hydrochloride (USAN)
D12618 Deucrictibant (USAN/INN)
D12908 Fidanacogene elaparvovec (USAN/INN)
D12992 Empasiprubart (USAN/INN)
Organism
Homo sapiens (human) [GN:
hsa ]
Gene
2152 F3; coagulation factor III, tissue factor [KO:K03901 ]
2165 F13B; coagulation factor XIII B chain [KO:K03906 ]
2149 F2R; coagulation factor II thrombin receptor [KO:K03914 ]
2151 F2RL2; coagulation factor II thrombin receptor like 2 [KO:K04235 ]
9002 F2RL3; F2R like thrombin or trypsin receptor 3 [KO:K04236 ]
5624 PROC; protein C, inactivator of coagulation factors Va and VIIIa [KO:K01344 ] [EC:3.4.21.69 ]
5054 SERPINE1; serpin family E member 1 [KO:K03982 ]
5055 SERPINB2; serpin family B member 2 [KO:K19821 ]
5104 SERPINA5; serpin family A member 5 [KO:K03913 ]
5270 SERPINE2; serpin family E member 2 [KO:K16643 ]
5329 PLAUR; plasminogen activator, urokinase receptor [KO:K03985 ]
623 BDKRB1; bradykinin receptor B1 [KO:K03915 ]
624 BDKRB2; bradykinin receptor B2 [KO:K03916 ]
7035 TFPI; tissue factor pathway inhibitor [KO:K03909 ]
5265 SERPINA1; serpin family A member 1 [KO:K03984 ]
462 SERPINC1; serpin family C member 1 [KO:K03911 ]
3053 SERPIND1; serpin family D member 1 [KO:K03912 ]
710 SERPING1; serpin family G member 1 [KO:K04001 ]
5345 SERPINF2; serpin family F member 2 [KO:K03983 ]
2 A2M; alpha-2-macroglobulin [KO:K03910 ]
5648 MASP1; MBL associated serine protease 1 [KO:K03992 ] [EC:3.4.21.-]
100293534 C4B_2; complement component 4B (Chido/Rodgers blood group), copy 2 [KO:K03989 ]
720 C4A; complement C4A (Chido/Rodgers blood group) [KO:K03989 ]
721 C4B; complement C4B (Chido/Rodgers blood group) [KO:K03989 ]
731 C8A; complement C8 alpha chain [KO:K03997 ]
732 C8B; complement C8 beta chain [KO:K03998 ]
733 C8G; complement C8 gamma chain [KO:K03999 ]
719 C3AR1; complement C3a receptor 1 [KO:K04009 ]
11326 VSIG4; V-set and immunoglobulin domain containing 4 [KO:K19822 ]
1378 CR1; complement C3b/C4b receptor 1 (Knops blood group) [KO:K04011 ]
1379 CR1L; complement C3b/C4b receptor 1 like [KO:K04011 ]
728 C5AR1; complement C5a receptor 1 [KO:K04010 ]
722 C4BPA; complement component 4 binding protein alpha [KO:K04002 ]
725 C4BPB; complement component 4 binding protein beta [KO:K04003 ]
1604 CD55; CD55 molecule (Cromer blood group) [KO:K04006 ]
3078 CFHR1; complement factor H related 1 [KO:K23815 ]
3080 CFHR2; complement factor H related 2 [KO:K23815 ]
966 CD59; CD59 molecule (CD59 blood group) [KO:K04008 ]
Compound
C03378 Coagulation factor VIIa
C03379 Coagulation factor XIIa
C04001 Coagulation factor VIIIa
C22531 Complement component 2a
C22532 Complement component 2b
C22533 Complement component 3b
C22534 Complement component 3f
C22536 Complement component 3dg
C22537 Complement component 3c
C22538 Complement component 3d
C22541 Complement component 4a
C22542 Complement component 4b
C22543 Complement component 4c
C22544 Complement component 4d
C22545 Complement component 5b
C22546 Coagulation factor XIIIa
Reference
Authors
Bajic G, Degn SE, Thiel S, Andersen GR
Title
Complement activation, regulation, and molecular basis for complement-related diseases.
Journal
Reference
Authors
Mathern DR, Heeger PS
Title
Molecules Great and Small: The Complement System.
Journal
Reference
Authors
Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT
Title
Complement System Part I - Molecular Mechanisms of Activation and Regulation.
Journal
Reference
Authors
Oikonomopoulou K, Ricklin D, Ward PA, Lambris JD
Title
Interactions between coagulation and complement--their role in inflammation.
Journal
Reference
Authors
Kurosawa S, Stearns-Kurosawa DJ
Title
Complement, thrombotic microangiopathy and disseminated intravascular coagulation.
Journal
Reference
Authors
Hillmeister P, Persson PB
Title
The Kallikrein-Kinin system.
Journal
Reference
Authors
Rau JC, Beaulieu LM, Huntington JA, Church FC
Title
Serpins in thrombosis, hemostasis and fibrinolysis.
Journal
Reference
Authors
Crooks MG, Hart SP
Title
Coagulation and anticoagulation in idiopathic pulmonary fibrosis.
Journal
Reference
Authors
Christiaans SC, Wagener BM, Esmon CT, Pittet JF
Title
Protein C and acute inflammation: a clinical and biological perspective.
Journal
Reference
Authors
Alberelli MA, De Candia E
Title
Functional role of protease activated receptors in vascular biology.
Journal
Reference
Authors
Smith HW, Marshall CJ
Title
Regulation of cell signalling by uPAR.
Journal
Reference
Authors
Ricklin D, Lambris JD
Title
Complement in immune and inflammatory disorders: pathophysiological mechanisms.
Journal
Reference
Authors
Ricklin D, Lambris JD
Title
Complement in immune and inflammatory disorders: therapeutic interventions.
Journal
Reference
Authors
Loof TG, Deicke C, Medina E
Title
The role of coagulation/fibrinolysis during Streptococcus pyogenes infection.
Journal
Reference
Authors
Jozsi M, Tortajada A, Uzonyi B, Goicoechea de Jorge E, Rodriguez de Cordoba S
Title
Factor H-related proteins determine complement-activating surfaces.
Journal
Related pathway
hsa04662 B cell receptor signaling pathway
hsa04750 Inflammatory mediator regulation of TRP channels
KO pathway